1-3 of 3
Michael Forsyth, RPh, MBA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Demographics, Treatment Patterns, Safety, and Real-World Effectiveness in Patients ≥70 Years of Age with Chronic Lymphocytic Leukemia Receiving Bendamustine with or without Rituximab,

Kathryn S. Kolibaba, MD, Avani D. Joshi, BPharm, PhD, James A. Sterchele, PharmD, Michael Forsyth, RPh, MBA, Erin Alwon, MS, Hooman Beygi, PhD, Gerard T. Kennealey, MD
Journal: Blood
Blood (2011) 118 (21): 3914.
https://doi.org/10.1182/blood.V118.21.3914.3914
Published: 2011
Journal Articles

Economic Impact of Disease Progression In Follicular Non-Hodgkin's Lymphoma.

Sacha-Satram Hoang, PhD, Stephen Gruschkus, PhD, Joseph Darragh, MS, Michael Forsyth, RPh, MBA, Roy Beveridge, MD, Carolina Reyes, PhD
Journal: Blood
Blood (2010) 116 (21): 1522.
https://doi.org/10.1182/blood.V116.21.1522.1522
Published: 2010
Journal Articles

Impact of Disease Progression On Healthcare Cost and Resource Utilization Among Follicular NHL Patients Treated within the US Oncology Network.

Stephen K Gruschkus, PhD, Joseph M Darragh, MA, Michael A Kolodziej, MD, Roy A Beveridge, MD, Michael Forsyth, RPh, MBA, Carolina Reyes, PhD
Journal: Blood
Blood (2009) 114 (22): 4543.
https://doi.org/10.1182/blood.V114.22.4543.4543
Published: 2009